ONCOSYNE AS
926191942ActiveDeveloping cancer treatments using patient-derived 3D tumoroid models.
Overview
- 6
- Employees
- 4.4M NOK
- Revenue
- 2020
- Founded
Key Decision Makers
Jarle Bruun
CEO and co-founder
Aarti Kapoor
Director, Strategic Partnerships
Peter W. Eide
CTO and co-founder
Christer Anker Andreassen
Product developer
+8 more contacts in Funnelfeedr
Description
Oncosyne operates at the forefront of precision oncology, utilizing its proprietary iCAN tumoroid platform. This platform creates living, patient-derived 3D tumor models that accurately mimic the characteristics of a patient's original cancer. For the pharmaceutical industry, Oncosyne offers compreh...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
12 contacts in FunnelfeedrJarle Bruun
CEO and co-founder
Aarti Kapoor
Director, Strategic Partnerships
Peter W. Eide
CTO and co-founder
Christer Anker Andreassen
Product developer
Other Contacts
Øyvind Bruland
Clinical advisor
Åke Andrén-Sandberg
Clinical advisor
Tine Norman Alver
Laboratory scientist
Janne Nestvold
Business advisor
+4 more contacts in Funnelfeedr
Similar Companies
20 similar companies in FunnelfeedrDOMORE DIAGNOSTICS AS
9 employeesDeveloping AI pathology tests for personalized cancer treatment decisions.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
RAB DIAGNOSTICS AS
Developing predictive biomarkers for optimizing Antibody-Drug Conjugate therapies.
HEMISPHERIAN AS
5 employeesDeveloping novel small molecule drugs targeting TET2 for aggressive cancers.
Browse More
ONCOSYNE AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo